$NTEC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intec Pharma Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Intec Pharma Ltd.. Get notifications about new insider transactions in Intec Pharma Ltd. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 18 2020 | NTEC | Intec Pharma Ltd. | Sassi Nir | Chief Financial Off ... | Option Exercise | A | 0.32 | 100,000 | 32,150 | 100,000 | |
| Sep 18 2020 | NTEC | Intec Pharma Ltd. | Linscott Walt Addison | Chief Business Offi ... | Option Exercise | A | 0.32 | 100,000 | 32,150 | 100,000 | |
| Sep 18 2020 | NTEC | Intec Pharma Ltd. | Navon Nadav | Chief Operating Off ... | Option Exercise | A | 0.32 | 100,000 | 32,150 | 100,000 | |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | Pomerantz Roger | Director | Option Exercise | A | 0.31 | 40,000 | 12,300 | 40,000 | |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Option Exercise | A | 0.31 | 300,000 | 92,250 | 300,000 | |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | MADDALUNA ANTHONY J | Director | Option Exercise | A | 0.31 | 40,000 | 12,300 | 40,000 | |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | Karah Hila | Director | Option Exercise | A | 0.31 | 40,000 | 12,300 | 40,000 | |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | Hayes William B | Director | Option Exercise | A | 0.31 | 40,000 | 12,300 | 40,000 | |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | KOZARICH JOHN W | Director | Option Exercise | A | 0.31 | 40,000 | 12,300 | 40,000 | |
| Feb 19 2020 | NTEC | Intec Pharma Ltd. | Sassi Nir | Chief Financial Off ... | Option Exercise | A | 0.43 | 90,000 | 38,583 | 90,000 | |
| Feb 19 2020 | NTEC | Intec Pharma Ltd. | Navon Nadav | Chief Operating Off ... | Option Exercise | A | 0.43 | 90,000 | 38,583 | 90,000 | |
| Feb 19 2020 | NTEC | Intec Pharma Ltd. | Linscott Walt Addison | Chief Business Offi ... | Option Exercise | A | 0.43 | 90,000 | 38,583 | 90,000 | |
| Feb 19 2020 | NTEC | Intec Pharma Ltd. | GENDREAU R MICHAEL | Chief Medical Offic ... | Option Exercise | A | 0.43 | 90,000 | 38,583 | 90,000 | |
| Feb 04 2020 | NTEC | Intec Pharma Ltd. | Dexcel Pharma Technologies Ltd ... | 10% Owner | Sell | S | 0.29 | 110,000 | 31,900 | 4,234,897 | 4.3 M to 4.2 M (-2.53 %) |
| Feb 04 2020 | NTEC | Intec Pharma Ltd. | Dexcel Pharma Technologies Ltd ... | 10% Owner | Sell | S | 0.32 | 80,000 | 25,440 | 4,344,897 | 4.4 M to 4.3 M (-1.81 %) |
| Feb 04 2020 | NTEC | Intec Pharma Ltd. | Dexcel Pharma Technologies Ltd ... | 10% Owner | Sell | S | 0.31 | 725,951 | 224,319 | 4,424,897 | 5.2 M to 4.4 M (-14.09 %) |
| Nov 21 2019 | NTEC | Intec Pharma Ltd. | Silberman Issac | Director | Buy | S | 0.50 | 1,000 | 504 | 4,000 | 3 K to 4 K (+33.33 %) |
| Sep 16 2019 | NTEC | Intec Pharma Ltd. | Sassi Nir | Chief Financial Off ... | Option Exercise | A | 0.90 | 200,000 | 180,000 | 200,000 | |
| Sep 16 2019 | NTEC | Intec Pharma Ltd. | Sassi Nir | Chief Financial Off ... | Option Exercise | A | 0.90 | 200,000 | 180,000 | 200,000 | |
| Sep 16 2019 | NTEC | Intec Pharma Ltd. | Linscott Walt Addison | Chief Business Offi ... | Option Exercise | A | 0.90 | 200,000 | 180,000 | 200,000 | |
| Sep 16 2019 | NTEC | Intec Pharma Ltd. | Linscott Walt Addison | Chief Business Offi ... | Option Exercise | A | 0.90 | 200,000 | 180,000 | 200,000 | |
| Aug 29 2019 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Buy | P | 0.68 | 20,000 | 13,620 | 196,761 | 176.8 K to 196.8 K (+11.31 %) |
| Aug 29 2019 | NTEC | Intec Pharma Ltd. | MADDALUNA ANTHONY J | Director | Buy | P | 0.47 | 25,000 | 11,750 | 53,570 | 28.6 K to 53.6 K (+87.50 %) |
| Aug 27 2019 | NTEC | Intec Pharma Ltd. | KOZARICH JOHN W | Director | Buy | P | 0.46 | 100,000 | 45,900 | 151,761 | 51.8 K to 151.8 K (+193.20 %) |
| Aug 27 2019 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Buy | P | 0.46 | 100,000 | 45,700 | 176,761 | 76.8 K to 176.8 K (+130.27 %) |
| Jul 02 2019 | NTEC | Intec Pharma Ltd. | Pomerantz Roger | Director | Option Exercise | A | 4.86 | 20,000 | 97,160 | 20,000 | |
| Jul 02 2019 | NTEC | Intec Pharma Ltd. | Pomerantz Roger | Director | Option Exercise | A | 4.86 | 20,000 | 97,160 | 20,000 | |
| Jul 02 2019 | NTEC | Intec Pharma Ltd. | MADDALUNA ANTHONY J | Director | Option Exercise | A | 4.86 | 20,000 | 97,160 | 20,000 | |
| Jul 02 2019 | NTEC | Intec Pharma Ltd. | MADDALUNA ANTHONY J | Director | Option Exercise | A | 4.86 | 20,000 | 97,160 | 20,000 | |
| Jul 02 2019 | NTEC | Intec Pharma Ltd. | Bianco Gil | Director | Option Exercise | A | 4.86 | 20,000 | 97,160 | 20,000 | |
| Jul 02 2019 | NTEC | Intec Pharma Ltd. | Bianco Gil | Director | Option Exercise | A | 4.86 | 20,000 | 97,160 | 20,000 | |
| Apr 05 2019 | NTEC | Intec Pharma Ltd. | Meckler Jeffrey A | Chief Executive Off ... | Option Exercise | A | 7.64 | 125,000 | 955,000 | 125,000 | |
| Jan 23 2019 | NTEC | Intec Pharma Ltd. | GENDREAU R MICHAEL | Chief Medical Offic ... | Option Exercise | A | 7.63 | 110,000 | 839,080 | 110,000 | |
| Jan 23 2019 | NTEC | Intec Pharma Ltd. | Linscott Walt Addison | Chief Business Offi ... | Option Exercise | A | 7.63 | 90,000 | 686,520 | 90,000 | |
| Jan 23 2019 | NTEC | Intec Pharma Ltd. | Navon Nadav | Chief Operating Off ... | Option Exercise | A | 7.63 | 90,000 | 686,520 | 90,000 | |
| Jan 23 2019 | NTEC | Intec Pharma Ltd. | Sassi Nir | Chief Financial Off ... | Option Exercise | A | 7.63 | 90,000 | 686,520 | 90,000 |
Page: 1